Drug Guide

Generic Name

Oxytetracycline

Brand Names Terramycin

Classification

Therapeutic: Antibiotic, Tetracycline class

Pharmacological: Protein synthesis inhibitor, bacteriostatic

FDA Approved Indications

  • Respiratory tract infections
  • Urinary tract infections
  • Skin infections
  • Ophthalmic infections
  • Anaplasmosis in cattle and sheep
  • Tick fever in dogs

Mechanism of Action

Oxytetracycline binds to the 30S ribosomal subunit, inhibiting the attachment of aminoacyl-tRNA to the mRNA-ribosome complex, thereby preventing protein synthesis and bacterial growth.

Dosage and Administration

Adult: Typically 250 to 500 mg every 6 to 12 hours, depending on infection severity and site.

Pediatric: Dosing based on weight, generally 25-50 mg/kg/day divided into 2-4 doses.

Geriatric: Adjust dose based on renal function, monitor for side effects.

Renal Impairment: Use with caution; dose adjustment may be necessary.

Hepatic Impairment: No specific adjustment recommended; monitor liver function during prolonged therapy.

Pharmacokinetics

Absorption: Orally absorbed with variable bioavailability; better absorption on an empty stomach.

Distribution: Widely distributed in body tissues and fluids, including cerebrospinal fluid and eye tissues.

Metabolism: Minimal hepatic metabolism.

Excretion: Primarily excreted unchanged in urine and feces.

Half Life: Approximately 8-12 hours.

Contraindications

  • Allergy to tetracyclines or other related antibiotics.

Precautions

  • Use with caution in pregnant women, nursing mothers, and children under 8 due to teeth discoloration and bone growth inhibition.
  • Monitor renal and hepatic function during prolonged therapy.

Adverse Reactions - Common

  • Gastrointestinal upset (nausea, vomiting, diarrhea) (Common)
  • Photosensitivity (Common)

Adverse Reactions - Serious

  • Hepatotoxicity (Rare)
  • Blood dyscrasias (Rare)
  • Superinfection (such as candida) (Rare)

Drug-Drug Interactions

  • Concurrent use with retinoids may increase intracranial pressure.
  • Calcium, magnesium, aluminum containing antacids and dairy products decrease absorption.

Drug-Food Interactions

  • Dairy products, antacids, iron supplements reduce bioavailability.

Drug-Herb Interactions

N/A

Nursing Implications

Assessment: Monitor for signs of allergic reactions, superinfection, liver and kidney function, gastrointestinal disturbances.

Diagnoses:

  • Risk for superinfection
  • Impaired gastrointestinal mobility

Implementation: Administer with or without food as tolerated; avoid dairy and antacids around dosing times; monitor labs.

Evaluation: Assess resolution of infection and monitor for adverse effects.

Patient/Family Teaching

  • Take medication exactly as prescribed.
  • Avoid dairy and antacids close to medication times.
  • Report signs of allergic reactions, liver problems, or superinfection.
  • Use sunscreen and protective clothing to prevent photosensitivity reactions.

Special Considerations

Black Box Warnings:

  • Discoloration of permanent teeth and enamel hypoplasia in children under 8; avoid use unless no alternatives are available.
  • Hepatotoxicity and intracranial hypertension in certain populations.

Genetic Factors: No specific genetic considerations noted.

Lab Test Interference: May cause false elevations of urinary catecholamines and serum creatinine.

Overdose Management

Signs/Symptoms: Gastrointestinal distress, dehydration, dizziness, and superinfection.

Treatment: Supportive care, gastrointestinal decontamination if early, and monitoring renal function.

Storage and Handling

Storage: Store at controlled room temperature (20-25°C), away from moisture, heat, and light.

Stability: Stable under proper storage conditions.

This guide is for educational purposes only and is not intended for clinical use.